KMID : 1149220080160020133
|
|
Korean Journal of Oriental Medical Prescription 2008 Volume.16 No. 2 p.133 ~ p.144
|
|
Clinical study of Bangpoongtongsungsan on body weight change in subjects with obesity
|
|
Shin Dae-Hee
Cho Guk-Hyun Lee Hyeok Moon Mi-Kyung Kang Dae-Gil Yun Young-Gab Park Do-Sim Juhng Seon-Kwan Lee Ho-Sub
|
|
Abstract
|
|
|
Recently, people are becoming fatter in most parts of the world. Obesity is regarded as an important risk factor to adversely affect the health of humans, associated with hypertension, hyperlipidemia, diabetes, and cardiovascular diseases. In the present study, therefore, we tested the short time efficiency and safety of Bangpoongtongsungsan as a drug to decrease body weight in subjects with obesity. A total 48 volunteers (24 man, 24 woman) with body mass index (BMI : weight in kg divided by square of height in meters) of participated in clinical study for 12 weeks, from 2008, March 01 to 2008, Jun 30. The subjects was received a dietary supplement of 12 pieces hard capsules per day (4 pieces in one, 3 times in a day) during the clinical study. At the end of clinical study, body weight of subjects was significantly decreased from to (p<0.05). Waist circumferences of subjects were reduced to (p<0.05). Also, a BMI of subjects was significantly decreased to (p<0.05). Particularly, a decrease in body weight, waist circumferences, and BMI was more significant in woman than man. But, other biochemical levels including lipid and glucose in plasma had no changes at the end of clinical study. In conclusion, administration of Bangpoongtongsungsan in subjects with high body weight fat could inhibit obesity associated with a decrease in body weight, waist circumferences, and BMI.
|
|
KEYWORD
|
|
Bangpoongtongsungsan, obesity, clinical study
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|